Amphiregulin in Fibrotic Diseases and Cancer

    June 2025 in “ Preprints.org ”
    Tae Rim Kim, Beomseok Son, Chun Geun Lee, Han-Oh Park

    Preprint — not peer reviewed. This was posted to a preprint server or data repository. It has not been through a journal's review process, and its findings may change or not hold up.

    Studysummary This review highlights the potential of amphiregulin as a therapeutic target, noting its role in both fibrotic and malignant diseases, and discusses promising early findings but reports no new clinical results.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on preprints.org →
    Discuss this study in the Community →